Page last updated: 2024-08-26

bosentan anhydrous and Cruveilhier-Baumgarten Syndrome

bosentan anhydrous has been researched along with Cruveilhier-Baumgarten Syndrome in 31 studies

Research

Studies (31)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (6.45)	18.2507
2000's	21 (67.74)	29.6817
2010's	8 (25.81)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Güllülü, S; Sağ, S; Yeşilbursa, D	1
Hatano, M; Imamura, T; Kinugawa, K; Komuro, I; Maki, H; Muraoka, H; Yao, A	1
Chuang, CL; Hsin, IF; Hsu, SJ; Huang, HC; Lee, FY; Lee, JY; Lee, SD; Lin, HC; Lin, TY; Wang, SS	1
Li, D; Matuschak, GM; Nayak, RP	1
Hayashida, A; Hino, T; Kawamoto, T; Neishi, Y; Obase, K; Okahashi, N; Okura, H; Wada, N; Watanabe, N; Yoshida, K	1
Csete, M; Heffron, T; Knowles, D; Lawrence, EC; Tapper, EB	1
Cavasin, MA; Chapo, J; Peng, Y; Pitts, K; Plato, CF; Sandoval, J; Semus, H	1
Eriksson, C; Gustavsson, A; Kronvall, T; Tysk, C	1
Andrews, JC; Kamath, PS; Krowka, MJ; Swanson, KL; Talwalkar, JA	1
Aizawa, Y; Ito, E; Maie, K; Ohno, Y; Sato, A; Tanabe, Y; Yoshida, T	1
Berrevoet, F; Colle, I; De Pauw, M; Geerts, A; Raevens, S; Reyntjens, K; Rogiers, X; Troisi, RI; Van Vlierberghe, H; Verhelst, X	1
Halank, M; Hoeffken, G; Miehlke, S; Schmeisser, A; Schulze, M; Strasser, RH	1
Bramhall, S; Clift, PF; Isaac, JL; Townend, JN	1
Alber, H; Colleselli, D; Kähler, CM; Molnar, C; Vogel, W	1
Graziadei, IW; Hinterhuber, L; Jaschke, W; Kähler, CM; Vogel, W	1
Gerbes, AL; Gülberg, V; Kuntzen, C	1
Halank, M; Hoeffken, G; Hoeper, MM; Marx, C; Niedermeyer, J; Schauer, J; Seyfarth, HJ; Winkler, J	1
Halank, M; Hoeffken, G; Kolditz, M; Miehlke, S	1
Halank, M; Hoeffken, G; Kolditz, M; Miehlke, S; Schiemanck, S; Schmeisser, A	1
Stähler, G; von Hunnius, P	1
Eller, P; Fuschelberger, R; Grander, W; Tilg, H	1
Gerbes, AL; Gülberg, V; Neuhofer, W	1
Barth, F; Dufour, JF; Gerber, PJ; Nicod, LP; Reichen, J	1
Boyer, L; Chabot, F; Gomez, E; Herve, P; Kheir, A; Le Pavec, J; Sitbon, O	1
Ashfaq, M; Ausloos, K; Chinnakotla, S; Davis, GL; Klintmalm, GB; Ramsay, M; Rogers, L; Saadeh, S	1
Halank, M; Hoeffken, G; Hoeper, MM; Pletz, MW; Seyfarth, HJ; Spiekerkoetter, E; Welte, T; Wirtz, H	1
Kawut, SM	1
Austin, MJ; Callender, ME; Heneghan, MA; Knisely, AS; McDougall, NI; O'Grady, JG; Rela, M; Sizer, E; Wendon, JA; Wilson, C	1
Burman, HP; Cahill, PA; O'Donnell, CP; Robotham, JL; Yamamoto, S	1
Cailmail, S; Calmus, Y; Clozel, M; Gadano, A; Gomola, A; Lebrec, D; Moreau, R; Sogni, P	1
Hashizume, M; Migoh, S; Sugimachi, K; Tanoue, K; Tsugawa, K	1

Reviews

4 review(s) available for bosentan anhydrous and Cruveilhier-Baumgarten Syndrome

Article	Year
Hepatotoxicity by bosentan in a patient with portopulmonary hypertension: a case-report and review of the literature. Journal of gastrointestinal and liver diseases : JGLD, 2011, Volume: 20, Issue:1 Topics: Adult; Antihypertensive Agents; Bosentan; Chemical and Drug Induced Liver Injury; Female; Humans; Hypertension, Portal; Hypertension, Pulmonary; Sulfonamides	2011
[Portopulmonary hypertension]. Zeitschrift fur Gastroenterologie, 2005, Volume: 43, Issue:7 Topics: Administration, Inhalation; Administration, Oral; Antihypertensive Agents; Bosentan; Epoprostenol; Hepatopulmonary Syndrome; Humans; Hypertension, Portal; Hypertension, Pulmonary; Iloprost; Infusions, Intravenous; Lung; Pulmonary Wedge Pressure; Sulfonamides; Survival Rate; Treatment Outcome; Vascular Resistance; Vasodilator Agents	2005
Endothelin and endothelin receptor antagonism in portopulmonary hypertension. European journal of clinical investigation, 2006, Volume: 36 Suppl 3 Topics: Administration, Oral; Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Cirrhosis; Liver Transplantation; Pulmonary Circulation; Sulfonamides; Treatment Outcome	2006
[Porto-pulmonary hypertension]. Revue des maladies respiratoires, 2006, Volume: 23, Issue:6 Topics: Antihypertensive Agents; Bosentan; Cardiac Catheterization; Drug Therapy, Combination; Echocardiography; Epoprostenol; Humans; Hypertension, Portal; Hypertension, Pulmonary; Oxygen Inhalation Therapy; Piperazines; Prognosis; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Treatment Outcome; Vasodilator Agents	2006

Other Studies

27 other study(ies) available for bosentan anhydrous and Cruveilhier-Baumgarten Syndrome

Article	Year
Treatment with a combination of bosentan and sildenafil allows for successful liver transplantation in a patient with portopulmonary hypertension. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2014, Volume: 25, Issue:4 Topics: Adult; Antihypertensive Agents; Bosentan; Drug Therapy, Combination; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Transplantation; Male; Piperazines; Purines; Sildenafil Citrate; Sulfonamides; Vasodilator Agents	2014
Secure Combination Therapy With Low-Dose Bosentan and Ambrisentan to Treat Portopulmonary Hypertension Minimizing Each Adverse Effect. International heart journal, 2015, Volume: 56, Issue:4 Topics: Antihypertensive Agents; Bosentan; Combined Modality Therapy; Diagnosis, Differential; Dose-Response Relationship, Drug; Echocardiography; Hemodynamics; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Cirrhosis; Male; Middle Aged; Phenylpropionates; Pyridazines; Sulfonamides; Treatment Outcome	2015
Endothelin receptor blockers reduce shunting and angiogenesis in cirrhotic rats. European journal of clinical investigation, 2016, Volume: 46, Issue:6 Topics: Animals; Bosentan; Collateral Circulation; Cyclooxygenase 2; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelin Receptor Antagonists; Hypertension, Portal; Liver Cirrhosis; Male; Neovascularization, Pathologic; Nitric Oxide Synthase Type II; Phenylpropionates; Phosphoproteins; Portal Pressure; Proto-Oncogene Proteins c-akt; Pyridazines; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sulfonamides; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2	2016
Portopulmonary hypertension. Current gastroenterology reports, 2009, Volume: 11, Issue:1 Topics: Antihypertensive Agents; Bosentan; Cardiac Catheterization; Echocardiography; Epoprostenol; Humans; Hypertension, Portal; Hypertension, Pulmonary; Iloprost; Liver Transplantation; Piperazines; Prognosis; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Vasodilator Agents	2009
Portopulmonary hypertension associated with congenital absence of the portal vein treated with bosentan. Internal medicine (Tokyo, Japan), 2009, Volume: 48, Issue:8 Topics: Antihypertensive Agents; Bosentan; Child; Humans; Hypertension, Portal; Hypertension, Pulmonary; Male; Portal Vein; Sulfonamides; Treatment Outcome	2009
Portopulmonary hypertension: imatinib as a novel treatment and the Emory experience with this condition. Transplantation proceedings, 2009, Volume: 41, Issue:5 Topics: Antihypertensive Agents; Benzamides; Bosentan; Epoprostenol; Female; Humans; Hypertension, Portal; Hypertension, Pulmonary; Imatinib Mesylate; Liver Failure; Liver Transplantation; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Sulfonamides; Treatment Outcome	2009
Acute effects of endothelin receptor antagonists on hepatic hemodynamics of cirrhotic and noncirrhotic rats. Canadian journal of physiology and pharmacology, 2010, Volume: 88, Issue:6 Topics: Animals; Antihypertensive Agents; Blood Pressure; Bosentan; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Gene Expression; Hemodynamics; Hepatic Stellate Cells; Hypertension, Portal; Liver; Liver Cirrhosis; Male; Oligopeptides; Peptides, Cyclic; Piperidines; Portal Pressure; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Regional Blood Flow; Sulfonamides	2010
Prevalence of spontaneous portosystemic shunts in patients with portopulmonary hypertension and effect on treatment. Gastroenterology, 2011, Volume: 141, Issue:5 Topics: Adult; Aged; Antihypertensive Agents; Bosentan; Case-Control Studies; Child; Drug Therapy, Combination; Epoprostenol; Female; Humans; Hypertension, Portal; Hypertension, Pulmonary; Magnetic Resonance Imaging; Male; Mesentery; Middle Aged; Piperazines; Purines; Regional Blood Flow; Renal Veins; Retrospective Studies; Severity of Illness Index; Sildenafil Citrate; Splenic Vein; Sulfonamides; Sulfones; Tomography, Spiral Computed; Treatment Outcome; Vena Cava, Inferior	2011
Efficacy and safety of bosentan treatment for portopulmonary hypertension associated with syncope. International heart journal, 2011, Volume: 52, Issue:4 Topics: Adult; Antihypertensive Agents; Bosentan; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Hypertension, Portal; Hypertension, Pulmonary; Male; Monitoring, Physiologic; Pulmonary Wedge Pressure; Sulfonamides; Syncope	2011
Oral vasodilator therapy in patients with moderate to severe portopulmonary hypertension as a bridge to liver transplantation. European journal of gastroenterology & hepatology, 2013, Volume: 25, Issue:4 Topics: Administration, Oral; Adult; Antihypertensive Agents; Bosentan; Combined Modality Therapy; Exercise Test; Female; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Transplantation; Male; Middle Aged; Phenylpropionates; Phosphodiesterase 5 Inhibitors; Pyridazines; Sulfonamides; Vasodilator Agents	2013
Use of oral endothelin-receptor antagonist bosentan in the treatment of portopulmonary hypertension. Transplantation, 2004, Jun-15, Volume: 77, Issue:11 Topics: Administration, Oral; Aged; Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Humans; Hypertension, Portal; Hypertension, Pulmonary; Male; Sulfonamides	2004
Successful treatment of severe portopulmonary hypertension after liver transplantation by bosentan. Transplantation, 2004, Jun-15, Volume: 77, Issue:11 Topics: Antihypertensive Agents; Bosentan; Female; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Transplantation; Middle Aged; Sulfonamides; Treatment Outcome	2004
Successful switch from inhalative iloprost to oral bosentan in portopulmonary hypertension associated with liver cirrhosis. Wiener klinische Wochenschrift, 2004, Sep-30, Volume: 116, Issue:17-18 Topics: Administration, Inhalation; Administration, Oral; Antihypertensive Agents; Bosentan; Drug Therapy, Combination; Female; Follow-Up Studies; Hemodynamics; Humans; Hypertension, Portal; Hypertension, Pulmonary; Iloprost; Liver Cirrhosis; Liver Transplantation; Middle Aged; Platelet Aggregation Inhibitors; Sulfonamides; Time Factors	2004
Endothelin-receptor antagonist treatment of portopulmonary hypertension. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2004, Volume: 2, Issue:11 Topics: Antihypertensive Agents; Bosentan; Female; Hemodynamics; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Cirrhosis; Middle Aged; Sulfonamides	2004
Use of a mixed endothelin receptor antagonist in portopulmonary hypertension: a safe and effective therapy? Gastroenterology, 2005, Volume: 128, Issue:1 Topics: Adult; Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Cirrhosis, Alcoholic; Male; Sulfonamides; Treatment Outcome	2005
Bosentan therapy for portopulmonary hypertension. The European respiratory journal, 2005, Volume: 25, Issue:3 Topics: Adult; Aged; Antihypertensive Agents; Bosentan; Exercise Tolerance; Female; Hemodynamics; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Oxygen Consumption; Retrospective Studies; Sulfonamides; Treatment Outcome	2005
Combination therapy for portopulmonary hypertension with intravenous iloprost and oral bosentan. Wiener medizinische Wochenschrift (1946), 2005, Volume: 155, Issue:15-16 Topics: Administration, Oral; Adult; Antihypertensive Agents; Bosentan; Drug Therapy, Combination; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Hypertension, Portal; Hypertension, Pulmonary; Iloprost; Injections, Intravenous; Liver Cirrhosis, Alcoholic; Male; Recurrence; Sulfonamides; Time Factors	2005
Successful treatment of portopulmonary hypertension with bosentan: case report. European journal of clinical investigation, 2006, Volume: 36 Suppl 3 Topics: Administration, Oral; Adult; Antihypertensive Agents; Bosentan; Echocardiography; Endothelin Receptor Antagonists; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Cirrhosis, Alcoholic; Male; Sulfonamides; Treatment Outcome; Vasodilation	2006
Bosentan treatment of portopulmonary hypertension related to liver cirrhosis owing to hepatitis C. European journal of clinical investigation, 2006, Volume: 36 Suppl 3 Topics: Administration, Oral; Aged; Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Hepatitis C, Chronic; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Cirrhosis; Male; Sulfonamides; Treatment Outcome	2006
Efficiency and safety of bosentan in child C cirrhosis with portopulmonary hypertension and renal insufficiency. European journal of gastroenterology & hepatology, 2006, Volume: 18, Issue:10 Topics: Adult; Antihypertensive Agents; Bosentan; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Cirrhosis; Male; Renal Insufficiency; Sulfonamides; Treatment Outcome	2006
The impact of treatment of portopulmonary hypertension on survival following liver transplantation. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2007, Volume: 7, Issue:5 Topics: Adult; Antihypertensive Agents; Blood Pressure; Bosentan; Diltiazem; Epoprostenol; Female; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Sulfonamides; Survival Rate; Treatment Outcome; Vasodilator Agents	2007
Experience with inhaled iloprost and bosentan in portopulmonary hypertension. The European respiratory journal, 2007, Volume: 30, Issue:6 Topics: Administration, Inhalation; Adult; Antihypertensive Agents; Bosentan; Catheterization; Disease-Free Survival; Female; Hemodynamics; Humans; Hypertension, Portal; Hypertension, Pulmonary; Iloprost; Male; Platelet Aggregation Inhibitors; Proportional Hazards Models; Sulfonamides; Treatment Outcome	2007
Caring for the orphan's orphan: treatment of patients with portopulmonary hypertension. The European respiratory journal, 2007, Volume: 30, Issue:6 Topics: Bosentan; Hemodynamics; Humans; Hypertension, Portal; Hypertension, Pulmonary; Iloprost; Patient Care; Sulfonamides; Survival Analysis	2007
Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2008, Volume: 14, Issue:3 Topics: Adult; Blood Pressure; Bosentan; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Hypertension, Portal; Hypertension, Pulmonary; Iloprost; Liver Diseases; Liver Transplantation; Male; Piperazines; Pulmonary Artery; Purines; Severity of Illness Index; Sildenafil Citrate; Sulfonamides; Sulfones; Treatment Outcome; Vasodilator Agents	2008
Endothelin causes portal and pulmonary hypertension in porcine endotoxemic shock. The American journal of physiology, 1997, Volume: 272, Issue:3 Pt 2 Topics: Analysis of Variance; Animals; Bosentan; Cyclooxygenase Inhibitors; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Endotoxemia; Hemodynamics; Hypertension, Portal; Hypertension, Pulmonary; Indomethacin; Liver Circulation; Portal System; Pulmonary Artery; Pulmonary Circulation; Regional Blood Flow; Shock, Septic; Sulfonamides; Swine; Thromboxane B2; Vascular Resistance	1997
Beneficial hemodynamic effects of bosentan, a mixed ET(A) and ET(B) receptor antagonist, in portal hypertensive rats. Hepatology (Baltimore, Md.), 1998, Volume: 28, Issue:3 Topics: Animals; Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Endothelin-1; Hemodynamics; Hypertension, Portal; Liver Cirrhosis, Experimental; Male; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Sulfonamides	1998
Role of endothelin-1 in congestive gastropathy in portal hypertensive rats. Journal of gastroenterology and hepatology, 2000, Volume: 15, Issue:2 Topics: Animals; Bosentan; Capillary Permeability; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Gastric Mucosa; Hypertension, Portal; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Stomach Diseases; Sulfonamides	2000